3,4-methylenedioxyamphetamine has been researched along with Abnormalities, Drug-Induced in 1 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bronson, ME | 1 |
| Barrios-Zambrano, L | 1 |
| Jiang, W | 1 |
| Clark, CR | 1 |
| DeRuiter, J | 1 |
| Newland, MC | 1 |
1 other study available for 3,4-methylenedioxyamphetamine and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Behavioral and developmental effects of two 3,4-methylenedioxymethamphetamine (MDMA) derivatives.
Topics: 3,4-Methylenedioxyamphetamine; Abnormalities, Drug-Induced; Animals; Appetitive Behavior; Arousal; B | 1994 |